WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Steven KannerChief Scientific Officer2024-02-0630,577$2.69
$82.25kBuy

1 of 1

CRBU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.69%6,947,820$12.99MInstitution
Vanguard Group Inc5.03%4,544,706$8.50MInstitution
Bank Of America Corp4.61%4,162,347$7.78MInstitution
Pfm Health Sciences LP4.52%4,083,372$7.64MInstitution
Rachel E. Haurwitz3.88%3,508,095$6.56MInsider
Fmr LLC3.68%3,323,284$6.21MInsider
Dimensional Fund Advisors LP2.90%2,623,283$4.91MInstitution
Point72 Asset Management LP2.59%2,343,540$4.38MInstitution
Elmwood Wealth Management Inc2.58%2,334,740$4.37MInstitution
Geode Capital Management LLC2.11%1,905,661$3.56MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU58.81%8.71%Net Buying
MOLN2.59%0.00%
LCTX39.50%60.50%Net BuyingNet Buying
ACHV54.09%27.74%Net BuyingNet Buying
GBIO64.46%35.54%Net BuyingNet Selling

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 58.81% institutional shareholders, 8.71% Caribou Biosciences insiders, and 32.48% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.51M shares representing 3.88% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $6.56M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.